Literature DB >> 19082566

Isolation of monoclonal antibody fragments from phage display libraries.

Mehdi Arbabi-Ghahroudi1, Jamshid Tanha, Roger MacKenzie.   

Abstract

Techniques developed over the past 20 years for the display of foreign peptides and proteins on the surfaces of filamentous bacteriophages have been a major driving force in the rapid development of recombinant antibody technology in recent years. With phage display of antibodies as one of its key components, recombinant antibody technology has led to the development of an increasing number of therapeutic monoclonal antibodies. Antibody gene libraries are fused to a gene encoding a phage coat protein. Recombinant phage expressing the resulting antibody libraries in fusion with the coat protein are propagated in Escherichia coli. Phage displaying monoclonal antibodies with specificities for target antigens are isolated from the libraries by a process called panning. The genes encoding the desired antibodies selected from the libraries are packaged within the phage particles, linking genotype and phenotype. Here, we describe the application of this technology to the construction of a phage-displayed single-domain antibody (sdAb) library based on the heavy chain antibody repertoire of a llama, the panning of the library against a peptide antigen and the expression, purification, and characterization of sdAbs isolated by panning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19082566     DOI: 10.1007/978-1-60327-565-1_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Yongrong Zhang; Gregorio Perez-Cordon; Tuxiong Huang; Jeremy Ramsey; Numan Oezguen; Tor C Savidge; Hanping Feng
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

2.  Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.

Authors:  Greg Hussack; Mehdi Arbabi-Ghahroudi; Henk van Faassen; J Glenn Songer; Kenneth K-S Ng; Roger MacKenzie; Jamshid Tanha
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

3.  A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface.

Authors:  Zhewei Tang; Mingqian Feng; Wei Gao; Yen Phung; Weizao Chen; Amit Chaudhary; Brad St Croix; Min Qian; Dimiter S Dimitrov; Mitchell Ho
Journal:  Mol Cancer Ther       Date:  2013-01-31       Impact factor: 6.261

4.  Pentavalent single-domain antibodies reduce Campylobacter jejuni motility and colonization in chickens.

Authors:  Ali Riazi; Philippa C R Strong; Russell Coleman; Wangxue Chen; Tomoko Hirama; Henk van Faassen; Matthew Henry; Susan M Logan; Christine M Szymanski; Roger Mackenzie; Mehdi Arbabi Ghahroudi
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies.

Authors:  Kevin A Henry; Traian Sulea; Henk van Faassen; Greg Hussack; Enrico O Purisima; C Roger MacKenzie; Mehdi Arbabi-Ghahroudi
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

6.  A Novel Affinity Tag, ABTAG, and Its Application to the Affinity Screening of Single-Domain Antibodies Selected by Phage Display.

Authors:  Greg Hussack; Toya Nath Baral; Jason Baardsnes; Henk van Faassen; Shalini Raphael; Kevin A Henry; Jianbing Zhang; C Roger MacKenzie
Journal:  Front Immunol       Date:  2017-10-30       Impact factor: 7.561

7.  A Novel Single Domain Antibody Targeting FliC Flagellin of Salmonella enterica for Effective Inhibition of Host Cell Invasion.

Authors:  Jennifer Huen; Zhun Yan; Jeremy Iwashkiw; Shraddha Dubey; Maria C Gimenez; Maria E Ortiz; Saumil V Patel; Michael D Jones; Ali Riazi; Mauricio Terebiznik; Saeid Babaei; Dea Shahinas
Journal:  Front Microbiol       Date:  2019-11-26       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.